Skip to content

6 articles found

BH

Buxton Helmsley Calls for Senate Hearing on Well-Documented Evident Clinical Data Fraud at Assertio

#Assertio Holdings, Inc. (ASRT)
Nov 14, 2024•7 min read
Press Releases
BH

Buxton Helmsley Releases Evidence of Product-Related Fraud at Assertio

#Assertio Holdings, Inc. (ASRT)
Nov 10, 2024•8 min read
Press Releases
BH

Buxton Helmsley Issues Letter to Assertio Stockholders Disclosing Inversion to Short Position Following Board Refusal to Address Product-Related Fraud

#Assertio Holdings, Inc. (ASRT)
Nov 7, 2024•8 min read
Press Releases
BH

Buxton Helmsley Issues Letter to the Board of Directors of Assertio Holdings, Inc.

#Assertio Holdings, Inc. (ASRT)
Jul 23, 2024•12 min read
Press Releases
BH

Buxton Helmsley Releases Letter From Certified Fraud Examiner Attesting To Disclosure Failures And Deficiencies By Assertio Holdings Board of Directors

#Assertio Holdings, Inc. (ASRT)
May 16, 2024•13 min read
Press Releases
BH

Buxton Helmsley Urges Assertio Stockholders to Vote “Against” Directors After Disclosure Failures, Inappropriate Boardroom Activity, Strategic Blunders

#Assertio Holdings, Inc. (ASRT)
May 12, 2024•13 min read
Press Releases
Stay Informed

The Buxton Helmsley Brief.

Briefings on markets, governance, and our investment philosophy—delivered directly.